• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers

tetano

Editor, Senior Moderator
Am J Obstet Gynecol. 2011 Apr 12. [Epub ahead of print]
Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers.

Steelfisher GK, Blendon RJ, Bekheit MM, Mitchell EW, Williams J, Lubell K, Peugh J, Disogra CA.

Harvard School of Public Health, Boston, MA.
Abstract

We sought to examine motivators and barriers related to monovalent 2009 influenza A (H1N1) vaccination among pregnant women. We conducted a national poll of pregnant women using a random online sample (237) and opt-in supplement (277). In all, 42% of pregnant women reported getting the vaccine. Vaccination was positively associated with attitudinal factors including believing the vaccine is very safe or benefits the baby, and with provider recommendations. Women in racial/ethnic minority groups, women with less education, and women <35 years were less likely to get the vaccine and had differing views and experiences. Despite H1N1 vaccination rates that are higher than past seasonal influenza rates, barriers like safety concerns may persist in a pandemic. Messaging from providers that encourages women to believe the vaccine is very safe and benefits their baby may be compelling. Messaging and outreach during future pandemics may require customization to increase vaccination among high-risk groups.
Copyright ? 2011 Mosby, Inc. All rights reserved.

PMID: 21492827 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/21492827
 
Back
Top Bottom